glp 1 afib Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis New research presented at #HRS2026

Name: glp 1 afib Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis New research presented at #HRS2026
Brand: businesscommunicationnetwork.com
SKU: 3345276848
Price: 25.78 USD
Availability: InStock
Rating: 4.844200000000001 (9 reviews)

SKU: 3345276848

4.8

USD25.78 USD51.78

Pay in 4 interest-free payments of $6.45 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

New research presented at #HRS2026 finds #GLP1 medications may reduce the risk of #AFib independent of weight loss. The findings suggest these therapies may influence heart rhythm through mechanisms beyond weight GLP 1 receptor agonists confer better outcomes after AF ablation in patients with diabetes Glucagon Like Peptide 1 Protects Against Atrial Fibrillation and Atrial Remodeling in Type 2 Diabetic Mice ScienceDirect Comparative Outcomes of GLP 1 Receptor Agonists vs Bariatric Surgery in Patients Undergoing Atrial Fibrillation Ablation JACC: Clinical Electrophysiology GLP 1 use cuts atrial fibrillation risk regardless of weight loss Complementary Yet Distinct Roles of GLP 1 Receptor Agonists and SGLT2 Inhibitors in Cardiovascular Risk Reduction

Store: businesscommunicationnetwork.com · Domain: businesscommunicationnetwork.com

Description

"Development and characterisation of a novel glucagon like peptide-1 receptor antibody"